Search In this Thesis
   Search In this Thesis  
العنوان
Prevalence of Peripheral Arterial Disease among End Stage Renal Disease Patients
الناشر
Faculty of medicine
المؤلف
Morkos,Ramy Raffat William
هيئة الاعداد
باحث / رامي رأفت وليم مرقس
مشرف / الأستاذ الدكتور/ هاني فؤاد حنا
مشرف / الأستاذ الدكتور/ أحمد شوقي الصيرفي
مشرف / الدكتور/ عادل محمد شبانة
تاريخ النشر
2019
عدد الصفحات
174 P.:
اللغة
الإنجليزية
الدرجة
ماجستير
التخصص
أمراض القلب والطب القلب والأوعية الدموية
تاريخ الإجازة
1/1/2019
مكان الإجازة
جامعة عين شمس - كلية الطب - أمراض القلب
الفهرس
Only 14 pages are availabe for public view

from 174

from 174

Abstract

Patients with End Stage Renal Disease are more susceptible to develop Peripheral Arterial Disease. so, screening is helpful for early diagnosis.
OBJECTIVES: The aim of this study is to screen and calculate the prevalence of asymptomatic patients on regular hemodialysis for presence of PAD.
METHODS: The study included 100 asymptomatic patients on regular hemodialysis and below 60 years old to be screened for presence of PAD. All selected patients have been subjected to ABI assessment using the Doppler. It was found that the prevalence of PAD among ESRD patients is 26% of which 80.8% had bilateral PAD and 19.2% had unilateral disease. The results showed that females had statistically significant higher risk of developing PAD that males. The study showed also that A1C level in patients who have no diabetes carries statistically significant results. The mean A1C level for the study group was 5.56 ± 0.70 and the control group was 4.92 ± 0.73. The p value was 0.000. The A1C level cut off value was > 5.3.
CONCLUSION: Renal impairment is an important risk factor for developing PAD in absence of traditional risk factors such as DM, hypertension, or dyslipidemia. Prevalence of PAD was 26% in our study. ABI is a simple non-invasive modality of screening for PAD. Females are at higher risk to develop PAD than males by ~ 2.7 fold. Although diabetes is absent, A1C level > 5.3 is significantly correlating with the risk of PAD.